Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CAI
CARIS LIFE SCIENCES, INC.
NASDAQ
$25.63
▼ DOWN 2.84% (-0.75)

KEY STATISTICS

Market Cap$7.25 B
52w High$38.68
52w Low$14.19
Dividend Yield—
Frequency—
P/E72.01
Volume3.83M
Shares Out.282.68M

COMPANY

LEADERSHIP

David Dean Halbert
CHIEF EXECUTIVE
David Dean Halbert

COMPENSATION 2026

Salary$764,918
Stock Awards$15,400,569
Incentive Plan Pay$0
All Other Comp.$925,773
Total$20,350,571

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 18, 2025
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
1,846

PRICE TARGET

Target High$33.00
Target Low$21.00
Target Median$24.00
Target Consensus$25.50

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$255.50M
NOV
4
WED

PRICE

$25.63 ▼ DOWN 2.84% (−$0.75)
$25.60$26.00$26.40$26.809:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM25.63

About Caris Life Sciences, Inc.

https://www.carislifesciences.com ↗

Caris Life Sciences, an AI-driven TechBio company founded in 2008 in Irving, Texas, offers molecular profiling and R&D services globally to transform cancer healthcare through tissue- and blood-based solutions and machine learning.

INDUSTRY

Biotechnology

A SERVICE CARIS LIFE SCIENCES, INC. IS KNOWN FOR

Caris Assure®

A liquid biopsy assay analyzing DNA and RNA from a blood sample to create a molecular cancer blueprint, enabling personalized treatment, early detection, and monitoring through minimally invasive sequencing.

COMPETITORS

COMPETITOR
GH COMPARE
NTRA COMPARE
TEM COMPARE
VCYT COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q1-2026Q2-2026
Pharma Research And Development Services$18.47M $9.25M ▼$5.37M ▼$11.46M ▲

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q1-2026Q2-2026
UNITED STATES$178.18M $213.55M ▲$213.84M ▲$261.57M ▲
NonUS$3.22M $3.28M ▲$2.34M ▼$2.14M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
158
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.00% · 4.1M
IBB
0.24% · 912.4K
DBXW.DE
0.11% · 620.4K
CSH2.PA
0.06% · 571.2K
TMSL
0.09% · 107.1K
GNOM
2.37% · 85.9K
FFSM
0.12% · 83.3K
INFO
0.18% · 60.8K
SCHC
0.03% · 56.5K
IPO
0.98% · 56.4K
FNY
0.23% · 51.5K
ZINN
0.83% · 41.9K
EQAL
0.13% · 41.7K
BBSC
0.11% · 30.9K
JHSC
0.10% · 27.0K
DRKY
2.74% · 19.8K
PTL
0.05% · 16.8K
GPT
1.49% · 13.7K
BIB
0.26% · 10.1K
RECS
0.00% · 9.6K
TILT
0.01% · 6.0K
BKSE
0.13% · 4.6K
GUSA
0.00% · 3.9K
SPEU
0.00% · 1.2K
TXS
0.06% · 964
DM
DMRI
0.02% · 731

INSTITUTIONAL OWNERSHIP

SHARES OWNED
48.82%
HOLDERS
329
TOP 12 OF 329 · RANKED BY POSITION SIZE
Fmr LLC
30.9M sh · $551.06M
Sixth Street Partners Management Company, L.P.
24.4M sh · $737.66M
J. H. Whitney Equity Partners Vi, LLC
20.3M sh · $546.52B
Coatue Management LLC
10.1M sh · $306.8M
Braidwell LP
8.3M sh · $147.12M
T. Rowe Price Investment Management, Inc.
8.0M sh · $242.78M
Pointstate Capital LP
7.4M sh · $131.6M
Price T Rowe Associates Inc /Md/
6.9M sh · $209.47M
Jpmorgan Chase & Co
6.6M sh · $120.24M
Blackrock, Inc.
5.5M sh · $98.67M
Silver Lake Group, L.L.C.
5.3M sh · $160.05M
Neuberger Berman Group LLC
4.3M sh · $109.08M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
Fredrickson David Paul
Purchase · 13.2K shares
2026-08-14
★
DIRECTOR
Vacirca Jeff L
Purchase · 13.2K shares
2026-08-14
★
DIRECTOR
Minor Lloyd
Purchase · 13.2K shares
2026-08-14
★
DIRECTOR
Gilliam Joseph E
Purchase · 13.2K shares
2026-08-14

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 2
BUY 2
OVERWEIGHT 1
HOLD 1
6 GRADES IN THE LAST 12 MONTHS
Evercore ISI Group OUTPERFORM BTIG BUY Citigroup BUY JP Morgan OVERWEIGHT Canaccord Genuity HOLD Baird OUTPERFORM

SECTORS PEERS

PEERPRICE
MRNA$137.99COMPARE
JAZZ$244.54COMPARE
HALO$105.35COMPARE
MDGL$533.76COMPARE
CORT$113.88COMPARE
CYTK$72.09COMPARE
ABVX$113.35COMPARE
RYTM$107.17COMPARE